Patient-Reported Outcome (PRO) as an Addition to Long-Term Results after High-Precision Stereotactic Radiotherapy in Patients with Secreting and Non-Secreting Pituitary Adenomas: A Retrospective Cohort Study up to 17-Years Follow-Up

High-precision radiotherapy has been established as a valid and effective treatment option in patients with pituitary adenomas. We report on outcome after fractionated stereotactic radiotherapy (FSRT) in correlation with patient-reported outcomes (PROs). We analyzed 69 patients treated between 2000...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessel, Kerstin A., Diehl, Christian D., Oechsner, Markus, Meyer, Bernhard, Gempt, Jens, Zimmer, Claus, Schmidt-Graf, Friederike, Combs, Stephanie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966568/
https://www.ncbi.nlm.nih.gov/pubmed/31783579
http://dx.doi.org/10.3390/cancers11121884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966568/
https://www.ncbi.nlm.nih.gov/pubmed/31783579
http://dx.doi.org/10.3390/cancers11121884

Ejemplares similares